Zimmer Biomet Holdings Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Zimmer Biomet Holdings, Inc. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue8.237.687.396.946.836.137.987.93
Cost of Revenue3.162.192.082.021.961.822.402.27
Gross Profit5.075.495.314.924.874.305.595.66
Operating Expenses
Research & Development0.460.440.460.410.440.320.450.39
Selling, General & Administrative3.252.932.842.762.842.523.343.38
Operating Expenses3.714.203.863.733.813.414.384.51
Operating Income1.361.291.451.190.860.891.211.15
Other Income/Expense
Interest Income0.000.000.000.000.000.000.000.00
Interest Expense0.290.220.200.160.21-0.210.000.29
Other Income/Expense-0.53-0.25-0.18-0.620.150.010.00-1.13
Income
Income Before Tax0.831.041.070.400.50-0.110.91-0.27
Income Tax Expense0.130.130.040.110.05-0.10-0.230.11
Net Income0.710.901.020.230.40-0.141.13-0.38
Net Income - Continuous Operations0.710.901.030.290.450.000.000.00
Net Income - Discontinued Operations0.000.000.00-0.06-0.040.000.000.00
EBITDA2.222.252.221.491.651.791.911.06
EBIT0.001.251.270.570.710.890.910.02
Depreciation & Amortization1.091.000.560.530.530.900.580.60
Earnings Per Share
Basic EPS4.004.005.001.002.00-1.006.00-2.00
Diluted EPS4.004.005.001.002.00-1.005.00-2.00
Basic Shares Outstanding0.200.200.210.210.210.210.210.20
Diluted Shares Outstanding0.200.200.210.210.210.210.210.20